GUILLERMO
LÓPEZ VIVANCO
Forscher bis um 2022
Hospital General de Granollers
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital General de Granollers (1)
2021
-
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study
Cancer Chemotherapy and Pharmacology, Vol. 87, Núm. 4, pp. 543-553